Advances in medical treatment of advanced hepatobiliary and pancreatic cancer in 2022

导出

摘要 This article summarizes the drug therapy progress of advanced hepatocellularcarcinoma, biliary tract cancer, and pancreatic cancer in 2022, includingchemotherapy, molecular targeted therapy, and immunotherapy, to providereference information for current clinical treatment and future clinicalresearch, and to better improve prognosis and quality of life in patients withhepatobiliary and pancreatic cancer.

作者 Le Zhang Rui Liu Ting Deng Yi Ba

机构地区 Department of Gastrointestinal Medical Oncology Department of Cancer Center

出处《Cancer Innovation》 2023年第1期36-51,共16页 肿瘤创新（英文）

基金 National Natural Science Foundation of China,Grant/Award Number:82072664。

关键词 hepatocellular carcinoma biliary tract cancer CHOLANGIOCARCINOMA pancreatic cancer CHEMOTHERAPY targeted therapy IMMUNOTHERAPY

分类号 R73 [医药卫生—肿瘤]

引文网络
相关文献

1Tingming Liang,Lin Jia,Rui Duan,Lulu Shen,Dekang Ren,Yujie Ren,Yuyang Dou,Li Guo.Inhibition of ALDH2 by disulfiram leads to synthetic lethality via ROS strikes twice in ARID1A-deficient cholangiocarcinoma[J].Genes & Diseases,2023,10(1):69-71.
2LI Mo Juan,XIONG Dan,WANG Shuai,HUANG Hao.Tra2βEnhances Cell Proliferation by Inducing the Expression of Transcription Factor SP1 in Cervical Cancer[J].Biomedical and Environmental Sciences,2023,36(2):146-159.
3Tianyin Ma,Zhang Chen,Yibo Chai,Xiangdong Gongye,Peng Xia,Chenming Qu,Ming Tian,Yufeng Yuan.Research progress on immunotherapy targeting the tumor immune microenvironment for cholangiocarcinoma[J].Oncology and Translational Medicine,2023,9(2):49-55. 被引量：1
4Jingtong Zhai,Yun Wu,Fei Ma,Virginia Kaklamani,Binghe Xu.Advances in medical treatment of breast cancer in 2022[J].Cancer Innovation,2023,2(1):1-17.
5蒋建平.了解急救小常识[J].疯狂英语（新读写）,2023(4):13-14.
6Anas Mahmoud,Abdalla Mohamed,Nizar Alyassin,Matthew Grossman,Yana Cavanagh.Cholangiocarcinoma, Primary Sclerosing Cholangitis, or IgG4-Sclerosing Cholangitis: Similar Presentations with Different Managements[J].Case Reports in Clinical Medicine,2023,12(4):108-112.
7Ze Ouyang,Weili Tao,Shiying Yu,Man Zou.Advances in pharmacotherapies in cancer-related cachexia[J].Oncology and Translational Medicine,2023,9(1):15-21.
8Yu Zhang,Yue Zhou,Yun-He Song,Xiu-Lan Zhang,Wei-Rong Chen.Secondary in-the-bag intraocular lens implantation combined with 120-and 360-degree goniotomy in glaucoma following congenital cataract surgery:a case report[J].International Journal of Ophthalmology(English edition),2023,16(4):659-662.
9Xu Yang,Nan Zhang,Yang Song,Xiaobo Yang,Xinting Sang,Haitao Zhao.Immunotherapy prototype Mark 3.0 model in primary liver cancer:adding locoregional stereotactic therapy and prognostic factors classification management[J].Medical Review,2022,2(6):547-552. 被引量：1
10胡雅菲,胡海洁,李富宇.胆管癌根治术是否可迈入微创时代[J].中华腔镜外科杂志（电子版）,2023,16(1):27-32.

Cancer Innovation

2023年第1期

浏览历史

内容加载中请稍等...

Advances in medical treatment of advanced hepatobiliary and pancreatic cancer in 2022

相关作者

相关机构

相关主题

浏览历史